Dataset Information

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

ABSTRACT: BACKGROUND: The genome-wide identification of both morbid genes, i.e., those genes whose mutations cause hereditary human diseases, and druggable genes, i.e., genes coding for proteins whose modulation by small molecules elicits phenotypic effects, requires experimental approaches that are time-consuming and laborious. Thus, a computational approach which could accurately predict such genes on a genome-wide scale would be invaluable for accelerating the pace of discovery of causal relationships between genes and diseases as well as the determination of druggability of gene products. RESULTS: In this paper we propose a machine learning-based computational approach to predict morbid and druggable genes on a genome-wide scale. For this purpose, we constructed a decision tree-based meta-classifier and trained it on datasets containing, for each morbid and druggable gene, network topological features, tissue expression profile and subcellular localization data as learning attributes. This meta-classifier correctly recovered 65% of known morbid genes with a precision of 66% and correctly recovered 78% of known druggable genes with a precision of 75%. It was than used to assign morbidity and druggability scores to genes not known to be morbid and druggable and we showed a good match between these scores and literature data. Finally, we generated decision trees by training the J48 algorithm on the morbidity and druggability datasets to discover cellular rules for morbidity and druggability and, among the rules, we found that the number of regulating transcription factors and plasma membrane localization are the most important factors to morbidity and druggability, respectively. CONCLUSIONS: We were able to demonstrate that network topological features along with tissue expression profile and subcellular localization can reliably predict human morbid and druggable genes on a genome-wide scale. Moreover, by constructing decision trees based on these data, we could discover cellular rules governing morbidity and druggability.

SUBMITTER: Costa PR

PROVIDER: S-EPMC3045802 | biostudies-literature | 2010

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

Costa Pedro R PR Acencio Marcio L ML Lemke Ney N

BMC genomics 20101222

<h4>Background</h4>The genome-wide identification of both morbid genes, i.e., those genes whose mutations cause hereditary human diseases, and druggable genes, i.e., genes coding for proteins whose modulation by small molecules elicits phenotypic effects, requires experimental approaches that are time-consuming and laborious. Thus, a computational approach which could accurately predict such genes on a genome-wide scale would be invaluable for accelerating the pace of discovery of causal relatio ...[more]

PMID: 21210975

Similar Datasets

Project description:California's almond growers face challenges with nitrogen management as new legislatively mandated nitrogen management strategies for almond have been implemented. These regulations require that growers apply nitrogen to meet, but not exceed, the annual N demand for crop and tree growth and nut production. To accurately predict seasonal nitrogen demand, therefore, growers need to estimate block-level almond yield early in the growing season so that timely N management decisions can be made. However, methods to predict almond yield are not currently available. To fill this gap, we have developed statistical models using the Stochastic Gradient Boosting, a machine learning approach, for early season yield projection and mid-season yield update over individual orchard blocks. We collected yield records of 185 orchards, dating back to 2005, from the major almond growers in the Central Valley of California. A large set of variables were extracted as predictors, including weather and orchard characteristics from remote sensing imagery. Our results showed that the predicted orchard-level yield agreed well with the independent yield records. For both the early season (March) and mid-season (June) predictions, a coefficient of determination (R 2) of 0.71, and a ratio of performance to interquartile distance (RPIQ) of 2.6 were found on average. We also identified several key determinants of yield based on the modeling results. Almond yield increased dramatically with the orchard age until about 7 years old in general, and the higher long-term mean maximum temperature during April-June enhanced the yield in the southern orchards, while a larger amount of precipitation in March reduced the yield, especially in northern orchards. Remote sensing metrics such as annual maximum vegetation indices were also dominant variables for predicting the yield potential. While these results are promising, further refinement is needed; the availability of larger data sets and incorporation of additional variables and methodologies will be required for the model to be used as a fertilization decision support tool for growers. Our study has demonstrated the potential of automatic almond yield prediction to assist growers to manage N adaptively, comply with mandated requirements, and ensure industry sustainability.

Project description:Background: The importance of being physically active and avoiding staying in bed has been recognized in stroke rehabilitation. However, studies have pointed out that stroke patients admitted to rehabilitation units often spend most of their day immobile and inactive, with limited opportunities for activity outside their bedrooms. To address this issue, it is necessary to record the duration of stroke patients staying in their bedrooms, but it is impractical for medical providers to do this manually during their daily work of providing care. Although an automated approach using wearable devices and access points is more practical, implementing these access points into medical facilities is costly. However, when combined with machine learning, predicting the duration of stroke patients staying in their bedrooms is possible with reduced cost. We assessed using machine learning to estimate bedroom-stay duration using activity data recorded with wearable devices. Method: We recruited 99 stroke hemiparesis inpatients and conducted 343 measurements. Data on electrocardiograms and chest acceleration were measured using a wearable device, and the location name of the access point that detected the signal of the device was recorded. We first investigated the correlation between bedroom-stay duration measured from the access point as the objective variable and activity data measured with a wearable device and demographic information as explanatory variables. To evaluate the duration predictability, we then compared machine-learning models commonly used in medical studies. Results: We conducted 228 measurements that surpassed a 90% data-acquisition rate using Bluetooth Low Energy. Among the explanatory variables, the period spent reclining and sitting/standing were correlated with bedroom-stay duration (Spearman's rank correlation coefficient (R) of 0.56 and -0.52, p < 0.001). Interestingly, the sum of the motor and cognitive categories of the functional independence measure, clinical indicators of the abilities of stroke patients, lacked correlation. The correlation between the actual bedroom-stay duration and predicted one using machine-learning models resulted in an R of 0.72 and p < 0.001, suggesting the possibility of predicting bedroom-stay duration from activity data and demographics. Conclusion: Wearable devices, coupled with machine learning, can predict the duration of patients staying in their bedrooms. Once trained, the machine-learning model can predict without continuously tracking the actual location, enabling more cost-effective and privacy-centric future measurements.

Project description:BackgroundWe aimed at predicting fatigue after breast cancer treatment using machine learning on clinical covariates and germline genome-wide data.MethodsWe accessed germline genome-wide data of 2799 early-stage breast cancer patients from the Cancer Toxicity study (NCT01993498). The primary endpoint was defined as scoring zero at diagnosis and higher than quartile 3 at 1 year after primary treatment completion on European Organization for Research and Treatment of Cancer quality-of-life questionnaires for Overall Fatigue and on the multidimensional questionnaire for Physical, Emotional, and Cognitive fatigue. First, we tested univariate associations of each endpoint with clinical variables and genome-wide variants. Then, using preselected clinical (false discovery rate < 0.05) and genomic (P < .001) variables, a multivariable preconditioned random-forest regression model was built and validated on a hold-out subset to predict fatigue. Gene set enrichment analysis identified key biological correlates (MetaCore). All statistical tests were 2-sided.ResultsStatistically significant clinical associations were found only with Emotional and Cognitive Fatigue, including receipt of chemotherapy, anxiety, and pain. Some single nucleotide polymorphisms had some degree of association (P < .001) with the different fatigue endpoints, although there were no genome-wide statistically significant (P < 5.00 × 10-8) associations. Only for Cognitive Fatigue, the predictive ability of the genomic multivariable model was statistically significantly better than random (area under the curve = 0.59, P = .01) and marginally improved with clinical variables (area under the curve = 0.60, P = .005). Single nucleotide polymorphisms found to be associated (P < .001) with Cognitive Fatigue belonged to genes linked to inflammation (false discovery rate adjusted P = .03), cognitive disorders (P = 1.51 × 10-12), and synaptic transmission (P = 6.28 × 10-8).ConclusionsGenomic analyses in this large cohort of breast cancer survivors suggest a possible genetic role for severe Cognitive Fatigue that warrants further exploration.

Dataset Information

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

Publications

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets